These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31977)

  • 41. Lymphokine-activated killer lymphocytes: National Cancer Institute clinical trials.
    Clark J; Longo DL
    Immunol Ser; 1989; 48():37-58. PubMed ID: 2488325
    [No Abstract]   [Full Text] [Related]  

  • 42. [Immunotherapy of cancer today and first trials of "modifiers of host-tumor relations"].
    Mathé G
    Rev Prat; 1981 Oct; 31(43):3057-60 passim. PubMed ID: 6170108
    [No Abstract]   [Full Text] [Related]  

  • 43. Translation of cancer immunotherapies.
    Skipper J; Hoffman EW; O'Donnell-Tormey J; Old LJ
    Nat Med; 2004 Nov; 10(11):1154-5; author reply 1155. PubMed ID: 15516901
    [No Abstract]   [Full Text] [Related]  

  • 44. BREAST CANCER: COMBINED CLINICAL STAFF CONFERENCE AT THE NATIONAL INSTITUTES OF HEALTH.
    ROSNER F; MUNTNER S
    Ann Intern Med; 1965 Aug; 63():321-41. PubMed ID: 14318474
    [No Abstract]   [Full Text] [Related]  

  • 45. Cancer immunotherapy: breaking the barriers to harvest the crop.
    Pardoll D; Allison J
    Nat Med; 2004 Sep; 10(9):887-92. PubMed ID: 15340404
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current status of the immunotherapy of cancer.
    N Z Med J; 1974 Apr; 79(513):874-5. PubMed ID: 4527726
    [No Abstract]   [Full Text] [Related]  

  • 47. Steroid receptors in breast cancer: an NIH Consensus Development Conference, Bethesda, Maryland, June 27-29, 1979.
    Cancer; 1980 Dec; 46(12 Suppl):2759-963. PubMed ID: 6108798
    [No Abstract]   [Full Text] [Related]  

  • 48. Proceedings of the American Cancer Society and National Cancer Institute National Conference on Nutrition in Cancer, June 29--July 1, 1978, Seattle, Washington.
    Cancer; 1979 May; 43(5 Suppl):1955-2162. PubMed ID: 36220
    [No Abstract]   [Full Text] [Related]  

  • 49. Adjuvant chemotherapy of breast cancer.
    Check WA
    JAMA; 1980 Sep; 244(10):1079, 1083-4. PubMed ID: 6106073
    [No Abstract]   [Full Text] [Related]  

  • 50. Molecular Targets in Cancer Therapy - Fourth Biennial Meeting. Mechanism and therapeutic reversal of immune suppression in cancer.
    Herber DL
    IDrugs; 2007 Apr; 10(4):227-9. PubMed ID: 17390239
    [No Abstract]   [Full Text] [Related]  

  • 51. International activities of the Division of Cancer Treatment, National Cancer Institute.
    Goldin A; Muggia FM; Rozencweig M
    Cancer Clin Trials; 1979; 2(1):29-35. PubMed ID: 519830
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Adjuvant immunotherapy with polyadenylic-polyuridylic acid (Poly A.Poly U) in operable cancer of the breast. Recent results of a controlled therapeutic trial].
    Lacour J; Lacour F; Spira A; Michelson M; Petit JY; Delage G; Sarrazin D; Contesso G; Viguier J
    Chirurgie; 1984; 110(4):418-24. PubMed ID: 6389040
    [No Abstract]   [Full Text] [Related]  

  • 53. Supportive therapy in burn care: Consensus Development Conference.
    Welsh J
    Am Pharm; 1979 Feb; 19(2):34. PubMed ID: 32760
    [No Abstract]   [Full Text] [Related]  

  • 54. Removal of third molars. National Institutes of Health Consensus Development Conference summary. Volume 2. Number 11.
    Tex Dent J; 1980 Jun; 98(6):6-7. PubMed ID: 6107997
    [No Abstract]   [Full Text] [Related]  

  • 55. Attempts towards improvement in cancer therapy.
    Seiler FR; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):1-2. PubMed ID: 6477348
    [No Abstract]   [Full Text] [Related]  

  • 56. US cancer institute funds trial of complementary therapy.
    Josefson D
    BMJ; 2000 Jun; 320(7251):1690. PubMed ID: 10864535
    [No Abstract]   [Full Text] [Related]  

  • 57. Immunotherapy: concepts and nursing implications.
    McCalla JL
    Nurs Clin North Am; 1976 Mar; 11(1):59-71. PubMed ID: 1083016
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunologically active biomaterials for cancer therapy.
    Ali OA; Mooney DJ
    Curr Top Microbiol Immunol; 2011; 344():279-97. PubMed ID: 20556594
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proceedings of the Mini-Symposium on Ovarian Carcinoma. May 19, 1978 Bethesda, Maryland.
    Cancer Treat Rep; 1979 Feb; 63(2):234-337. PubMed ID: 36229
    [No Abstract]   [Full Text] [Related]  

  • 60. [Principles of adjuvant therapy with immunomodulators].
    Betzler M
    Aktuelle Probl Chir Orthop; 1982; 22():24-9. PubMed ID: 6121509
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.